Inhibition of interferon-γ signaling by Leishmania donovani

Journal of Infectious Diseases

Volumn 181, Issue 3, 2000, Pages 1121-1128

  Ray, Mitali ^a,b   Gam, Albert A ^a   Boykins, Robert A ^a   Kenney, Richard T ^a,c  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR;

ARTICLE; CYTOKINE PRODUCTION; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEISHMANIA DONOVANI; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTOZOAL INFECTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; DNA-BINDING PROTEINS; GLYCOSPHINGOLIPIDS; HUMANS; INTERFERON TYPE II; LEISHMANIA DONOVANI; PHOSPHORYLATION; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TYROSINE; U937 CELLS;

EID: 0034127543     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315330     Document Type: Article

References (47)

1. 1. Alexander J, Russell DG. The interaction of Leishmania species with macrophages. Adv Parasitol 1992;31:175-254.
2. 2. Unanue ER, Allen PM. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 1987;236:551-7.
3. 3. Reiner NE, Ng W, Wilson CB, McMaster WR, Burchett SK. Modulation of in vitro monocyte cytokine responses to Leishmania donovani: interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1. J Clin Invest 1990; 85:1914-24.
4. 4. Descoteaux A, Matlashewski G. c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages. Mol Cell Biol 1989;9:5223-7.
5. 5. Buchmuller-Rouiller Y, Mauel J. Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp. Infect Immun 1987;55:587-93.
6. 6. Carrera L, Gazzinelli RT, Badolato R, et al. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow derived macrophages from susceptible and resistant mice. J Exp Med 1996;183:515-26.
7. 7. Murray HW, Masur H, Keithly JS. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. J Immunol 1982;129:344-50.
8. 8. Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol 1989;143:266-74.
9. 9. Reiner NE, Ng W, Ma T, McMaster WR. Kinetics of gamma interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages. Proc Natl Acad Sci USA 1988;85:4330-4.
10. 10. Nandan D, Reiner NE. Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect Immun 1995;63:4495-500.
11. 11. Igarashi K, Garotta G, Ozmen L, et al. Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. J Biol Chem 1994;269:14333-6.
12. 12. Sakatsume M, Igarashi K, Winestock KD, Garotta G, Larner AC, Finbloom DS. The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. J Biol Chem 1995;270:17528-34.
13. 13. Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J, Schreiber RD. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 1995;2:677-87.
14. 14. Greenlund AC, Farrar MA, Viviano BL, Schreiber RD. Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). Embo J 1994;13:1591-600.
15. 15. Lucas DM, Lokuta MA, McDowell MA, Doan JE, Paulnock DM. Analysis of the IFN-gamma-signaling pathway in macrophages at different stages of maturation. J Immunol 1998;160:4337-42.
16. 16. Muskus C, Segura I, Oddone R, et al. Carbohydrate and LPG expression in Leishmania viannia subgenus. J Parasitol 1997;83:671-8.
17. 17. Dutta M, Bandyopadhyay R, Basu MK. Neoglycosylated liposomes as efficient ligands for the evaluation of specific sugar receptors on macrophages in health and in experimental leishmaniasis. Parasitology 1994; 109:139-47.
18. 18. Jaffe CL, Rachamim N, Sarfstein R. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis. J Immunol 1990;144:699-706.
19. 19. Joshi M, Dwyer DM, Nakhasi HL. Cloning and characterization of differentially expressed genes from in vitro grown "amastigotes" of Leishmania donovani. Mol Biochem Parasitol 1993;58:345-54.
20. 20. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-9.
21. 21. Hayashi RJ, Loh DY, Kanagawa O, Wang F. Differences between responses of naive and activated T cells to anergy induction. J Immunol 1998;160: 33-8.
22. 22. Wilson KC, Finbloom DS. Interferon gamma rapidly induces in human monocytes a DNA-binding factor that recognizes the gamma response region within the promoter of the gene for the high-affinity Fc gamma receptor. Proc Natl Acad Sci USA 1992;89:11964-8.
23. 23. McConville MJ, Bacic A, Mitchell GF, Handman E. Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor. Proc Natl Acad Sci USA 1987;84:8941-5.
24. 24. Aguet M, Dembic Z, Merlin G. Molecular cloning and expression of the human interferon-gamma receptor. Cell 1988;55:273-80.
25. 25. Igarashi K, David M, Larner AC, Finbloom DS. In vitro activation of a transcription factor by gamma interferon requires a membrane-associated tyrosine kinase and is mimicked by vanadate. Mol Cell Biol 1993;13: 3984-9.
26. 26. Desjardos M, Descoteaux A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med 1997;185:2061-8.
27. 27. Piedranta D, Proudfoot L, Nikolaev AV, et al. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur J Immunol 1999;29: 235-44.
28. + T cells and accompanied by over-production of IL-12, IFN-gamma and TNF-alpha. J Immunol 1996;157: 798-805.
29. 29. Olivier M, Brownsey RW, Reiner NE. Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc Natl Acad Sci USA 1992;89:7481-5.
30. 30. Reiner NE. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today 1994;15:374-81.
31. 31. Kwan WC, McMaster WR, Wong N, Reiner NE. Inhibition of expression of major histocompatibility complex class II molecules in macrophages infected with Leishmania donovani occurs at the level of gene transcription via a cyclic AMP-independent mechanism. Infect Immun 1992;60: 2115-20.
32. 32. Bach EA, Tanner JW, Marsters S, et al. Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol Cell Biol 1996;16:3214-21.
33. 33. Pestka S, Kotenko SV, Muthukumaran G, Izotova LS, Cook JR, Garotta G. The interferon gamma (IFN-gamma) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev 1997;8: 189-206.
34. 34. Bach EA, Aguet M, Schreiber RD. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997;15:563-91.
35. 35. Rodig S, Kaplan D, Shankaran V, Old L, Schreiber RD. Signaling and signaling dysfunction through the interferon gamma receptor. Eur Cytokine Netw 1998;9:49-53.
36. 36. Finbloom DS. Internalization and degradation of human recombinant interferon-gamma in the human histiocytic lymphoma cell line, U937: relationship to Fc receptor enhancement and antiproliferation. Clin Immunol Immunopathol 1988;47:93-105.
37. 37. Finbloom DS. Regulation of cell-surface receptors for human interferon-gamma on the human histiocytic lymphoma cell line U937. Biochem J 1991;274:775-80.
38. 38. Hershey GK, McCourt DW, Schreiber RD. Ligand-induced phosphorylation of the human interferon-gamma receptor: dependence on the presence of a functionally active receptor. J Biol Chem 1990;265:17868-75.
39. 39. Fountoulakis M, Zulauf M, Lustig A, Garotta G. Stoichiometry of interaction between interferon gamma and its receptor. Eur J Biochem 1992;208:781-7.
40. 40. Greenlund AC, Schreiber RD, Goeddel DV, Pennica D. Interferon-gamma induces receptor dimerization in solution and on cells. J Biol Chem 1993;268:18103-10.
41. 41. Marsters SA, Pennica D, Bach E, Schreiber RD, Ashkenazi A. Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc Natl Acad Sci USA 1995;92: 5401-5.
42. 42. Proudfoot L, Nikolaev AV, Feng GJ, et al. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci USA 1996;93:10984-9.
43. 43. Hussain S, Zwilling BS, Lafuse WP. Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor. J Immunol 1999;163:2041-8.
44. 44. Merlin G, van der Leede BJ, McKune K, et al. The gene for the ligand binding chain of the human interferon gamma receptor. Immunogenetics 1997;45:413-21.
45. 45. Rhee S, Ebensperger C, Dembic Z, Pestka S. The structure of the gene for the second chain of the human interferon-gamma receptor. J Biol Chem 1996;271:28947-52.
46. 46. Sanceau J, Merlin G, Wietzerbin J. Tumor necrosis factor-alpha and IL-6 up-regulate IFN-gamma receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms. J Immunol 1992;149:1671-5.
47. 47. Celada A, Schreiber RD. Internalization and degradation of receptor-bound interferon-gamma by murine macrophages: demonstration of receptor recycling. J Immunol 1987;139:147-53.